Sun Pharmaceutical Industries has asked a US federal judge for the right to appeal a court ruling rejecting the company’s request for dismissal of a multidistrict lawsuit alleging violation of antitrust and consumer laws.
The litigation being heard by a Boston court against Sun and its US subsidiary Ranbaxy Inc. involves five consolidated...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?